glp 1 gip gcg Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Structural basis for the therapeutic
Description
doi: 10.1016/j.ejphar.2016.04.052
A representative will contact you within 24 hours
Nomiyama T, Kawanami T, Irie S, Hamaguchi Y, Terawaki Y, Murase K, et al
Kerscher, J
When GLP-1 or GLP-1R agonists bind to these receptors, they trigger a cAMP response, which inhibits platelet aggregation
